Hedvat CV - Search Results

1

Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray.

Chitale DA, Jungbluth AA, Marshall DS, Leitao MM, Hedvat CV, Kolb D, Spagnoli GC, Iversen K, Soslow RA. Chitale DA, et al. Among authors: hedvat cv. Mod Pathol. 2005 Jan;18(1):119-26. doi: 10.1038/modpathol.3800232. Mod Pathol. 2005. PMID: 15272278 Free article.

2

Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.

Dhodapkar MV, Osman K, Teruya-Feldstein J, Filippa D, Hedvat CV, Iversen K, Kolb D, Geller MD, Hassoun H, Kewalramani T, Comenzo RL, Coplan K, Chen YT, Jungbluth AA. Dhodapkar MV, et al. Among authors: hedvat cv. Cancer Immun. 2003 Jul 23;3:9. Cancer Immun. 2003. PMID: 12875607

3

Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray.

Dupont J, Wang X, Marshall DS, Leitao M, Hedvat CV, Hummer A, Thaler H, O'Reilly RJ, Soslow RA. Dupont J, et al. Among authors: hedvat cv. Gynecol Oncol. 2004 Aug;94(2):449-55. doi: 10.1016/j.ygyno.2004.05.014. Gynecol Oncol. 2004. PMID: 15297187

4

Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.

Busam KJ, Hedvat C, Pulitzer M, von Deimling A, Jungbluth AA. Busam KJ, et al. Am J Surg Pathol. 2013 Mar;37(3):413-20. doi: 10.1097/PAS.0b013e318271249e. Am J Surg Pathol. 2013. PMID: 23211290

5

Melan-A (A103) and inhibin expression in ovarian neoplasms.

Yao DX, Soslow RA, Hedvat CV, Leitao M, Baergen RN. Yao DX, et al. Among authors: hedvat cv. Appl Immunohistochem Mol Morphol. 2003 Sep;11(3):244-9. doi: 10.1097/00129039-200309000-00007. Appl Immunohistochem Mol Morphol. 2003. PMID: 12966351

6

Lysophosphatidic acid acyltransferase-beta (LPAAT-beta) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival.

Diefenbach CS, Soslow RA, Iasonos A, Linkov I, Hedvat C, Bonham L, Singer J, Barakat RR, Aghajanian C, Dupont J. Diefenbach CS, et al. Cancer. 2006 Oct 1;107(7):1511-9. doi: 10.1002/cncr.22184. Cancer. 2006. PMID: 16944535 Free article.

7

Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome.

Wadehra M, Natarajan S, Seligson DB, Williams CJ, Hummer AJ, Hedvat C, Braun J, Soslow RA. Wadehra M, et al. Cancer. 2006 Jul 1;107(1):90-8. doi: 10.1002/cncr.21957. Cancer. 2006. PMID: 16736513 Free article.

8

Tumor promoting properties of the ETS protein MEF in ovarian cancer.

Yao JJ, Liu Y, Lacorazza HD, Soslow RA, Scandura JM, Nimer SD, Hedvat CV. Yao JJ, et al. Among authors: hedvat cv. Oncogene. 2007 Jun 7;26(27):4032-7. doi: 10.1038/sj.onc.1210170. Epub 2007 Jan 8. Oncogene. 2007. PMID: 17213815

9

Macrophage-derived chemokine expression in classical Hodgkin's lymphoma: application of tissue microarrays.

Hedvat CV, Jaffe ES, Qin J, Filippa DA, Cordon-Cardo C, Tosato G, Nimer SD, Teruya-Feldstein J. Hedvat CV, et al. Mod Pathol. 2001 Dec;14(12):1270-6. doi: 10.1038/modpathol.3880473. Mod Pathol. 2001. PMID: 11743050

10

Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma.

Hedvat CV, Hegde A, Chaganti RS, Chen B, Qin J, Filippa DA, Nimer SD, Teruya-Feldstein J. Hedvat CV, et al. Hum Pathol. 2002 Oct;33(10):968-74. doi: 10.1053/hupa.2002.127438. Hum Pathol. 2002. PMID: 12395368

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters